The Joint Corp.
NASDAQ:JYNTMedical - Care Facilities
+$0.17 today
- Market cap
- $91.03M
- Beta
- 1.10
- P/E (TTM)
- 40.7
- EPS (TTM)
- $0.23
Volume 0.05M
Average 0.07M
JYNT Revenue
Total income from selling goods and services before any costs are deducted; the top line of the income statement.
The Joint Corp.NASDAQ: JYNT
Revenue · Q1 FY2026 · quarter ended Mar 2026
Revenue grows, but more slowly than its trailing trend
Q1 FY2026 revenue of $14.82M rose 13.3% year over year, behind the +221.8% change in trailing-twelve-month revenue. Sequentially, it fell 2.3% from the prior quarter. Over 3 fiscal years it compounded at -18.5% a year.
Context
- Revenue increased in 2 of the last 3 fiscal years.
What to watch
Whether revenue reaches the consensus estimate from 3 analysts of $58.12M (+5.9%) for the fiscal year ending Dec 2026, a pace similar to FY2025.
Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterMar 2026
- $14.82M-2.3% QoQ
- Last fiscal yearDec 2025
- $54.9M+5.2% YoY
- LTMMar 2026
- $56.64M+221.8% YoY
| Horizon | Past | Forecast | Difference |
|---|---|---|---|
| Quarter | +13.3% | +9.8% | -3.5 pp |
| 1 year | +5.2% | +5.9% | +0.6 pp |
| 3-year CAGR | -18.5% | +0.6% | +19.0 pp |
| 5-year CAGR | — | — | |
| 10-year CAGR | — | — |
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
Revenue history
USD · from the income statement
- Latest · FY2025
- 54.9M USD
- Year-over-year change
- +5.2%
- 4-year CAGR
- -9.0%
| Period | Period end | Revenue | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 54.9M | +5.2% |
| FY2024 | 2024-12-31 | 52.16M | +11.0% |
| FY2023 | 2023-12-31 | 46.98M | -53.6% |
| FY2022 | 2022-12-31 | 101.25M | +26.5% |
| FY2021 | 2021-12-31 | 80.01M | — |
Revenue vs competitors
How JYNT compares with its peers on the latest reported figures
- JYNT's LTM Mar 2026 revenue of $56.64M is the 4th highest of the 11 companies compared; the peer median is $19.76M.
- Its year-over-year change of +221.8% is the highest of 8, against a peer median of +10.3%.
- Over three fiscal years its annual growth of -18.5% compares with a peer median of +5.2%.
| Company | Period | LTM | YoY | 3-year CAGR |
|---|---|---|---|---|
| LTM Mar 2026 | $301.71M | -42.0% | -9.9% | |
| LTM Mar 2026 | $188.16M | -5.6% | +5.2% | |
| LTM Mar 2026 | $124.14M | +10.3% | -4.6% | |
| LTM Mar 2026 | $56.64M | +221.8% | -18.5% | |
| LTM Mar 2026 | $55.9M | +18.2% | +5.9% | |
| LTM Mar 2026 | $34.38M | +16.0% | +25.2% | |
| LTM Mar 2026 | $5.13M | +23.0% | +132.0% | |
| LTM Mar 2026 | $396.9K | — | — | |
| LTM Mar 2026 | $57K | -50.4% | -32.9% | |
| LTM Mar 2026 | $0 | — | — | |
| LTM Mar 2026 | $0 | — | — | |
| Peer median (excluding JYNT) | $19.76M | +10.3% | +5.2% | |
Competitors are the stored peer set for JYNT. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 80.01M | 101.25M | 46.98M | 52.16M | 54.9M |
| Cost of Revenue | 7.67M | 9.17M | 10.48M | 11.52M | 11.23M |
| Gross Profit | 72.35M | 92.08M | 36.5M | 40.65M | 43.67M |
| Gross Margin | 90.4% | 90.9% | 77.7% | 77.9% | 79.6% |
| Research & Development | 0 | 0 | 0 | 0 | 0 |
| Selling, General & Admin | 62.27M | 81.95M | 34.92M | 41.1M | 42.93M |
| Operating Expenses | 66.22M | 91.25M | 36.18M | 42.54M | 44.58M |
| Depreciation & Amortization | 3.92M | 6.65M | 8.58M | 4.72M | 1.71M |
| EBITDA | 10.07M | 7.89M | 8.88M | 2.9M | 1.48M |
| EBITDA Margin | 12.6% | 7.8% | 18.9% | 5.6% | 2.7% |
| Operating Income | 6.13M | 828.25K | 318.3K | (1.89M) | (905.48K) |
| Operating Margin | 7.7% | 0.8% | 0.7% | -3.6% | -1.6% |
| Interest Income | 0 | 133.1K | 0 | 280.29K | 0 |
| Interest Expense | 0 | 953.53K | 64.29K | 0 | 0 |
| Other Income / Expenses | (69.88K) | (133.1K) | (64.29K) | 280.29K | 675.97K |
| Income Before Tax | 6.06M | 695.15K | 254.01K | (1.61M) | (229.5K) |
| Pre-Tax Margin | 7.6% | 0.7% | 0.5% | -3.1% | -0.4% |
| Income Tax Expense | (1.51M) | 68.45K | 11.02M | 5.61K | 38.65K |
| Net Income | 7.57M | 626.71K | (9.75M) | (5.8M) | 2.91M |
| Net Margin | 9.5% | 0.6% | -20.8% | -11.1% | 5.3% |
| EPS (Basic) | 0.46 | 0.04 | (0.66) | (0.39) | 0.19 |
| EPS (Diluted) | 0.44 | 0.04 | (0.66) | (0.39) | 0.19 |
| Weighted Avg Shares | 14.32M | 14.49M | 14.69M | 14.92M | 15.13M |
| Weighted Avg Shares (Diluted) | 14.94M | 14.87M | 14.69M | 15.15M | 15.13M |
The Joint Corp.
NASDAQ:JYNT
Intrinsic Alpha fair value
Locked
Current Price
$6.65
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.